Predict chances for a successful transfer and pregnancy

ReceptivaDX is a first of its kind test for the detection of BCL6. High levels of BCL6 indicates inflammation usually associated with endometriosis, limiting the ability of the embryo to stick to the endometrial lining.

Women testing positive for ReceptivaDX are 5 times less likely to succeed in IVF than women testing negative. If a woman tests positive and endometriosis is suspected it can then be treated by your physician to increase your chances of success. A negative BCL6 result provides reassurance to patients that endometriosis is not of concern and that future attempts at pregnancy are likely to be successful.

For more information about ReceptivaDX, please contact our patient care advocate.